DV
Dividend Vision

HSDT — Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc. (HSDT)

Total return is -100.0% over the past 12.1 years, 484.9 points behind SPY at 384.9%. Its deepest 1-year drawdown was 94.7%.

HSDT is a healthcare equity security focused on small-cap medical technology. The fund does not currently offer dividend distributions, making it unsuitable for income-focused investors seeking regular payouts. This holding appeals primarily to growth-oriented investors seeking exposure to smaller healthcare innovation companies rather than those prioritizing yield.

HSDT key facts

Asset type
Stock
Asset class
Equity
Inception date
06/27/2014
Last close
$1.70
Market cap
$99,257,352
Average volume
137300.0
Payment date
01/04/2021
Beta
1.012
Payout ratio
0.0
P/E ratio
0.0045
Forward P/E
0.0
EPS
$379.14